Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kristy Seidel

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 7, 2016
Endocrine Abnormalities in Aging Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor StudySogol Mostoufi-Moab, Kristy Seidel, Wendy M Leisenring, et al.
Blood Advances|August 12, 2024
Feasibility and favorable responses after investigational CAR T-cell therapy for relapsed and refractory infant ALLColleen Annesley, Adam Lamble, Corinne Summers, et al.
Neuro-Oncology|October 11, 2017
Longitudinal assessment of late-onset neurologic conditions in survivors of childhood central nervous system tumors: a Childhood Cancer Survivor Study reportElizabeth M Wells, Nicole J Ullrich, Kristy Seidel, et al.
Neuro-Oncology|January 1, 2017
Long-term neurologic health and psychosocial function of adult survivors of childhood medulloblastoma/PNET: a report from the Childhood Cancer Survivor StudyAllison A King, Kristy Seidel, Chongzhi Di, et al.
The Lancet. Oncology|September 1, 2019
Solid organ transplantation after treatment for childhood cancer: a retrospective cohort analysis from the Childhood Cancer Survivor StudyAndrew C Dietz, Kristy Seidel, Wendy M Leisenring, et al.
Cancer Immunology Research|May 17, 2022
Modified Manufacturing Process Modulates CD19CAR T-cell Engraftment Fitness and Leukemia-Free Survival in Pediatric and Young Adult SubjectsFrancesco Ceppi, Ashley L Wilson, Colleen Annesley, et al.
Nature Medicine|July 13, 2021
Locoregional infusion of HER2-specific CAR T cells in children and young adults with recurrent or refractory CNS tumors: an interim analysisNicholas A Vitanza, Adam J Johnson, Ashley L Wilson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2024
STRIvE-02: A First-in-Human Phase I Study of Systemically Administered B7-H3 Chimeric Antigen Receptor T Cells for Patients With Relapsed/Refractory Solid TumorsNavin Pinto, Catherine M Albert, Mallory R Taylor, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 18, 2026
The first-in-human ENCIT01 trial comparing second- versus third-generation L1CAM-specific CAR T cells in patients with primary refractory or relapsed neuroblastomaNavin Pinto, Annette Künkele, Catherine M Albert, et al.
Journal of the National Cancer Institute|February 13, 2018
A High-risk Haplotype for Premature Menopause in Childhood Cancer Survivors Exposed to Gonadotoxic TherapyRussell J Brooke, Cindy Im, Carmen L Wilson, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 7, 2016
Endocrine Abnormalities in Aging Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor StudySogol Mostoufi-Moab, Kristy Seidel, Wendy M Leisenring, et al.
Blood Advances|August 12, 2024
Feasibility and favorable responses after investigational CAR T-cell therapy for relapsed and refractory infant ALLColleen Annesley, Adam Lamble, Corinne Summers, et al.
Neuro-Oncology|October 11, 2017
Longitudinal assessment of late-onset neurologic conditions in survivors of childhood central nervous system tumors: a Childhood Cancer Survivor Study reportElizabeth M Wells, Nicole J Ullrich, Kristy Seidel, et al.
Neuro-Oncology|January 1, 2017
Long-term neurologic health and psychosocial function of adult survivors of childhood medulloblastoma/PNET: a report from the Childhood Cancer Survivor StudyAllison A King, Kristy Seidel, Chongzhi Di, et al.
The Lancet. Oncology|September 1, 2019
Solid organ transplantation after treatment for childhood cancer: a retrospective cohort analysis from the Childhood Cancer Survivor StudyAndrew C Dietz, Kristy Seidel, Wendy M Leisenring, et al.
Cancer Immunology Research|May 17, 2022
Modified Manufacturing Process Modulates CD19CAR T-cell Engraftment Fitness and Leukemia-Free Survival in Pediatric and Young Adult SubjectsFrancesco Ceppi, Ashley L Wilson, Colleen Annesley, et al.
Nature Medicine|July 13, 2021
Locoregional infusion of HER2-specific CAR T cells in children and young adults with recurrent or refractory CNS tumors: an interim analysisNicholas A Vitanza, Adam J Johnson, Ashley L Wilson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2024
STRIvE-02: A First-in-Human Phase I Study of Systemically Administered B7-H3 Chimeric Antigen Receptor T Cells for Patients With Relapsed/Refractory Solid TumorsNavin Pinto, Catherine M Albert, Mallory R Taylor, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 18, 2026
The first-in-human ENCIT01 trial comparing second- versus third-generation L1CAM-specific CAR T cells in patients with primary refractory or relapsed neuroblastomaNavin Pinto, Annette Künkele, Catherine M Albert, et al.
Journal of the National Cancer Institute|February 13, 2018
A High-risk Haplotype for Premature Menopause in Childhood Cancer Survivors Exposed to Gonadotoxic TherapyRussell J Brooke, Cindy Im, Carmen L Wilson, et al.
Pageof 5